Neomycin Granules

(Product under development)
Neomycin Granules Neomycin is an aminoglycoside antibiotic that is found in many topical medications such as creams, ointments, and eyedrops. The discovery of Neomycin dates back to 1949. It was discovered in the lab of Selman Waksman, who was later awarded the Nobel Prize in Physiology and medicine in 1951. Neomycin, belongs to aminoglycoside class of antibiotics which contain two or more aminosugars connected by glycosidic bonds.

Neamine (two rings), Ribostamycin (three rings), Paromomycin (four rings) and Lividomycin (five rings) are some other examples of aminoglycosides. They have shown tremendous potential as antibacterials. One of them, Gentamicin has been used extensively in clinical practice. Due to the inherent oto and nephrotoxicity of these substances, systemic use has declined as safer alternatives have become available.

Available Form:
Neomycin Granules
Neomycin Pellets

Umang Pharmatech equipments used for production of Neomycin Granules:
Drug Layering, Fluid Bed Dryer, Fluid Bed Coater, Sifter & Blender, Extruder and Twin spheronizer.

Neomycin Granules
Systematic (IUPAC) Name
Neomycin Granules
Identifiers
Neomycin Granules
Chemical data
((1R,2R,3S,4R,6S)-4,6-diamino-2-
CAS number : 1404-04-2
ATC code : A01AB08 A07AA01, B05CA09, D06AX04, J01GB05, R02AB01, S01AA03, S02AA07, S03AA01
PubChem : CID 8378
IUPHAR ligand : 709
DrugBank : DB00994
ChemSpider : 8075
UNII : I16QD7X297
KEGG : D08260
ChEBI : CHEBI:7508
ChEMBL : CHEMBL449118
Formula : C23H46N6O13
Mol. mass : 614.644 g/mol


* All transactions are carried out in conformity with patent laws applicable in the user country. Active pharmaceutical ingredients or formulations thereof will not be supplied in countries where the same is under patent protection except as and if permitted under law of the country for research and development purposes only.
Extruder Spheronizer Email Us Umang Pharmatech
TESTIMONIAL